Study Looking at Side Effects of Patients with Leukemia

What we are studying

In the United States, nearly 500 children, adolescents and young adults are diagnosed with Acute Myeloid Leukemia (AML) every year and half are cured with standard therapy. In other words, half of the children, adolescents and young adults diagnosed with AML remain with no signs of cancer (remission) for 5 years. The overall goal of this study is to see if we can increase this cure rate without causing more serious side effects of therapy. Side effects are unintended and unwanted results of treatment.

Who is Eligible

  • Genders:
    • Men
    • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • All Ages up to 29

Eligibility Criteria

  • Diagnosed with Acute Myeloid Leukemia (AML)

What is involved

  • Treatment will last about 6 to 8 months
  • Follow-Up will occur for about 10 years



Contact Information

Study Coordinator
Graham Keyes

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.